Regulation of IDO2 by the Aryl Hydrocarbon Receptor (AhR) in Breast Cancer
Indoleamine 2,3-dioxygenase 2 (IDO2) is a tryptophan-catabolizing enzyme and a homolog of IDO1 with a distinct expression pattern compared with IDO1. In dendritic cells (DCs), IDO activity and the resulting changes in tryptophan level regulate T-cell differentiation and promote immune tolerance. Rec...
Main Authors: | Sarah Y. Kado, Keith Bein, Alejandro R. Castaneda, Arshia A. Pouraryan, Nicole Garrity, Yasuhiro Ishihara, Andrea Rossi, Thomas Haarmann-Stemmann, Colleen A. Sweeney, Christoph F. A. Vogel |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/10/1433 |
Similar Items
-
Immunological relevance of the coevolution of IDO1 and AHR
by: Francisco Javier Quintana, et al.
Published: (2014-10-01) -
The Coevolution of IDO1 and AhR in the Emergence of Regulatory T Cells in Mammals
by: Ursula eGrohmann, et al.
Published: (2015-02-01) -
The Role of the Aryl Hydrocarbon Receptor (AhR) and Its Ligands in Breast Cancer
by: Stephen Safe, et al.
Published: (2022-11-01) -
Aryl Hydrocarbon Receptor Signaling Synergizes with TLR/NF-κB-Signaling for Induction of IL-22 Through Canonical and Non-Canonical AhR Pathways
by: Yasuhiro Ishihara, et al.
Published: (2022-02-01) -
Cancer immunotherapy by targeting IDO1/TDO and their downstream effectors
by: Michael ePlatten, et al.
Published: (2015-01-01)